Predict your next investment

Venture Capital
spraypartners.com

See what CB Insights has to offer

Investments

62

Portfolio Exits

11

Funds

3

About Spray Venture Partners

Spray Venture Partners focuses exclusively on investments in emerging healthcare technology companies. Spray Venture Partners prefers to work with clinical and technical founders to create companies that develop, market and deploy innovative technologies to meet major unmet healthcare needs. Per the firm, they prefer to partner with: (1) Clinicians or engineers with a product idea, (2) CEOs looking for early stage venture capital and (3) Healthcare executives interested in joining an exciting early-stage technology company with experienced and helpful investors.

Spray Venture Partners Headquarters Location

2330 Washington Street

Newton, Massachusetts, 02462,

United States

617-332-6060

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Spray Venture Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Spray Venture Partners in 1 Expert Collection, including Fitness Tech.

F

Fitness Tech

227 items

We define fitness tech as companies leveraging software and technology to augment approaches to developing or maintaining physical fitness. Companies in this category develop tools and services including workout apps, wearables, and connected fitness equipment.

Latest Spray Venture Partners News

Australia’s Blue Sky Participates in $12M Conventus Raising

Oct 9, 2013

Australia's Blue Sky Participates in $12M Conventus Raising Gillian Tan Join Now Sign In Members Only This is the kind of news coverage and analysis you can access exclusively as a WSJ Pro Member. Copyright 2016 Dow Jones & Company, Inc. All Rights Reserved This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

Spray Venture Partners Investments

62 Investments

Spray Venture Partners has made 62 investments. Their latest investment was in Solace Therapeutics as part of their Series E - II on February 2, 2020.

CBI Logo

Spray Venture Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/12/2020

Series E - II

Solace Therapeutics

$6.53M

No

2

10/11/2018

Series D - II

Vapotherm

$10M

Yes

1

12/16/2016

Series H

Intrinsic Therapeutics

$28.43M

No

3

9/6/2016

Series D

Subscribe to see more

$99M

Subscribe to see more

10

10/29/2015

Series A - III

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/12/2020

10/11/2018

12/16/2016

9/6/2016

10/29/2015

Round

Series E - II

Series D - II

Series H

Series D

Series A - III

Company

Solace Therapeutics

Vapotherm

Intrinsic Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$6.53M

$10M

$28.43M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

3

10

10

Spray Venture Partners Portfolio Exits

11 Portfolio Exits

Spray Venture Partners has 11 portfolio exits. Their latest portfolio exit was Vapotherm on November 14, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/14/2018

IPO

$99M

Public

5

9/6/2017

Acquired

$99M

3

12/4/2014

Acquired

$99M

1

7/8/2012

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

1/10/2011

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/14/2018

9/6/2017

12/4/2014

7/8/2012

1/10/2011

Exit

IPO

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

5

3

1

10

10

Spray Venture Partners Fund History

3 Fund Histories

Spray Venture Partners has 3 funds, including Spray Venture Fund II LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

3/1/2004

Spray Venture Fund II LP

Early-Stage Venture Capital

Closed

$72M

1

9/1/1998

Spray Venture Fund LP

Subscribe to see more

Subscribe to see more

$99M

10

Spray Venture Fund III LP

Subscribe to see more

Subscribe to see more

10

Closing Date

3/1/2004

9/1/1998

Fund

Spray Venture Fund II LP

Spray Venture Fund LP

Spray Venture Fund III LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Amount

$72M

$99M

Sources

1

10

10

Spray Venture Partners Team

4 Team Members

Spray Venture Partners has 4 team members, including current General Partner, Daniel Cole.

Name

Work History

Title

Status

Daniel Cole

General Partner

Current

Kevin Connors

General Partner

Current

Paul F Falvey

Chief Financial Officer

Former

Paal Gisholt

General Partner

Former

Name

Daniel Cole

Kevin Connors

Paul F Falvey

Paal Gisholt

Work History

Title

General Partner

General Partner

Chief Financial Officer

General Partner

Status

Current

Current

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.